Breast Cancer Clinical Trial

MRI Evaluation of the Breast Areolar Margin and Paryenchyma

Summary

The purpose of this study is to test a new method of defining patterns of how breast glands are or are not attached to the overlying skin. All patients will have markers placed on both breasts and will undergo an MRI. MRI results will be examined to identify the pattern of breast gland attachment to the overlying skin. This will help identify patients which may benefit from areolar sparing and/or nipple sparing technique and which patients should be treated by standard mastectomy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Have one of the following indications for MRI study of the breast - screening for high risk without evidence of disease, have existing breast cancer with need for evaluation of extent of disease or to rule out additional occult cancer, or to have an equivocal mammogram or ultrasound requiring additional information from MRI.
No prior breast surgery including prior excisional biopsies for disease performed with surgical technique, breast augmentation, reduction mammoplasty or breast lift with or without implants.
Capable of fitting into the MRI machine.
Permission to contact and consent the patient to participate from the investigator(s)
Provide written informed consent and Authorization for Use/Disclosure of PHI

Exclusion Criteria:

Have a contraindication to MRI study.
Prior breast surgery - this includes: prior excisional biopsies for disease performed with surgical technique, breast augmentation, reduction mammoplasty or breast lift with or without implants [Patients may have undergone prior percutaneous (needle) biopsy or fine needle aspiration]
Inability to fit into the MRI machine.
Psychological factors that may interfere with successful completion of the study
Refusal to provide written informed consent and/or Authorization for Use/Disclosure of PHI

Study is for people with:

Breast Cancer

Estimated Enrollment:

68

Study ID:

NCT01300585

Recruitment Status:

Terminated

Sponsor:

Piedmont Healthcare

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Piedmont Hospital
Atlanta Georgia, 30309, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

68

Study ID:

NCT01300585

Recruitment Status:

Terminated

Sponsor:


Piedmont Healthcare

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider